Validation of the International Classification of Functioning, Disability and Health (ICF) Core Set for rheumatoid arthritis from the patient perspective using focus groups

Michaela Coenen, Alarcos Cieza, Tanja A Stamm, Edda Amann, Barbara Kollerits, Gerold Stucki, Michaela Coenen, Alarcos Cieza, Tanja A Stamm, Edda Amann, Barbara Kollerits, Gerold Stucki

Abstract

Functioning is recognized as an important study outcome in rheumatoid arthritis (RA). The Comprehensive ICF Core Set for RA is an application of the International Classification of Functioning, Disability and Health (ICF) of the World Health Organisation with the purpose of representing the typical spectrum of functioning of patients with RA. To strengthen the patient perspective, persons with RA were explicitly involved in the validation of the Comprehensive ICF Core Set for RA using qualitative methodology. The objective of the study was twofold: to come forward with a proposal for the most appropriate methodology to validate Comprehensive ICF Core Sets from the patient perspective; and to add evidence to the validation of the Comprehensive ICF Core Set for RA from the perspective of patients. The specific aims were to explore the aspects of functioning and health important to patients with RA using two different focus group approaches (open approach and ICF-based approach) and to examine to what extent these aspects are represented by the current version of the Comprehensive ICF Core Set for RA. The sampling of patients followed the maximum variation strategy. Sample size was determined by saturation. The focus groups were digitally recorded and transcribed verbatim. The meaning condensation procedure was used for the data analysis. After qualitative data analysis, the resulting concepts were linked to ICF categories according to established linking rules. Forty-nine patients participated in ten focus groups (five in each approach). Of the 76 ICF categories contained in the Comprehensive ICF Core Set for RA, 65 were reported by the patients based on the open approach and 71 based on the ICF-based approach. Sixty-six additional categories (open approach, 41; ICF-based approach, 57) that are not covered in the Comprehensive ICF Core Set for RA were raised. The existing version of the Comprehensive ICF Core Set for RA could be confirmed almost entirely by the two different focus group approaches applied. Focus groups are a highly useful qualitative method to validate the Comprehensive ICF Core Set for RA from the patient perspective. The ICF-based approach seems to be the most appropriate technique.

Figures

Figure 1
Figure 1
The bio-psycho-social model of functioning, disability and health.
Figure 2
Figure 2
Saturation of the qualitative data in the focus groups. ICF, International Classification of Functioning, Disability and Health.

References

    1. Cieza A, Stucki G. Understanding functioning, disability, and health in rheumatoid arthritis: the basis for rehabilitation care. Curr Opin Rheumatol. 2005;17:183–189. doi: 10.1097/01.bor.0000151405.56769.e4.
    1. Stucki G, Ewert T, Cieza A. Value and application of the ICF in rehabilitation medicine. Disabil Rehabil. 2002;24:932–938. doi: 10.1080/09638280210148594.
    1. Fries JF, Spitz P, Kraines RG, Holman HR. Measurement of patient outcome in arthritis. Arthritis Rheum. 1980;23:137–145.
    1. Meenan RF, Mason JH, Anderson JJ, Guccione AA, Kazis LE. AIMS 2. Arthritis Rheum. 1992;35:1–10.
    1. Guyatt GH, Feeny DH, Patrick DL. Measuring health-related quality of life. Ann Intern Med. 1993;118:622–629.
    1. Cieza A, Brockow T, Ewert T, Amman E, Kollerits B, Chatterji S, Üstün TB, Stucki G. Linking health-status measurements to the International Classification of Functioning, Disability and Health. J Rehabil Med. 2002;34:205–210. doi: 10.1080/165019702760279189.
    1. Cieza A, Geyh S, Chatterji S, Kostanjsek N, Üstün B, Stucki G. ICF linking rules: an update based on lessons learned. J Rehabil Med. 2005;37:212–218. doi: 10.1080/16501970510040263.
    1. Stucki G, Cieza A. The International Classification of Functioning, Disability and Health (ICF) Core Sets for rheumatoid arthritis: a way to specify functioning. Ann Rheum Dis. 2004;63(Suppl 2):ii40–ii45. doi: 10.1136/ard.2004.028233.
    1. Carr A. Beyond disability: measuring the social and personal consequences of osteoarthritis. Osteoarthritis Cartilage. 1999;7:230–238. doi: 10.1053/joca.1998.0154.
    1. Schneidert M, Hurst R, Miller J, Üstün B. The role of environment in the International Classification of Functioning, Disability and Health (ICF) Disabil Rehabil. 2003;25:588–595. doi: 10.1080/0963828031000137090.
    1. Ueda S, Okawa Y. The subjective dimension of functioning and disability: what is it and what is it for? Disabil Rehabil. 2003;25:596–601. doi: 10.1080/0963828031000137108.
    1. Üstün TB, Chatterji S, Bickenbach J, Kostanjsek N, Schneider M. The International Classification of Functioning, Disability and Health: a new tool for understanding disability and health. Disabil Rehabil. 2003;25:565–571. doi: 10.1080/0963828031000137063.
    1. Albers JM, Kuper HH, van Riel PL, Prevoo ML, van't Hof MA, van Gestel AM, Severens JL. Socio-economic consequences of rheumatoid arthritis in the first years of the disease. Rheumatology (Oxford) 1999;38:423–430. doi: 10.1093/rheumatology/38.5.423.
    1. Sokka T, Kautiainen H, Mottonen T, Hannonen P. Work disability in rheumatoid arthritis 10 years after the diagnosis. J Rheumatol. 1999;26:1681–1685.
    1. Young A, Dixey J, Cox N, Davies P, Devlin J, Emery P, Gallivan S, Gough A, James D, Prouse P, et al. How does functional disability in early rheumatoid arthritis (RA) affect patients and their lives? Results of 5 years of follow-up in 732 patients from the Early RA Study (ERAS) Rheumatology (Oxford) 2000;39:603–611. doi: 10.1093/rheumatology/39.6.603.
    1. Katz PP. The impact of rheumatoid arthritis on life activities. Arthritis Care Res. 1995;8:272–278.
    1. World Health Organization . International Classification of Functioning, Disability and Health: ICF. Geneva: WHO; 2001.
    1. Stucki G, Cieza A, Ewert T, Kostanjsek N, Chatterji S, Üstün TB. Application of the International Classification of Functioning, Disability and Health (ICF) in clinical practice. Disabil Rehabil. 2002;24:281–282. doi: 10.1080/09638280110105222.
    1. Cieza A, Ewert T, Üstün TB, Chatterji S, Kostansjek N, Stucki G. ICF Core Sets development for patients with chronic conditions. J Rehabil Med. 2004;44(Suppl):9–11.
    1. Weigl M, Cieza A, Andersen C, Kollerits B, Amann E, Stucki G. Identification of relevant ICF categories in patients with chronic health conditions: A Delphi exercise. J Rehabil Med. 2004;44(Suppl):12–21. doi: 10.1080/16501960410015443.
    1. Brockow T, Cieza A, Kuhlow H, Sigl T, Franke T, Harder M, Stucki G. Identifying the concepts contained in outcome measures of clinical trials on musculoskeletal disorders and chronic wide spread pain using the International Classification of Functioning, Disability and Health as a reference. J Rehabil Med. 2004;44(Suppl):30–36. doi: 10.1080/16501960410015371.
    1. Ewert T, Fuessl M, Cieza A, Andersen C, Chatterji S, Kostanjsek N, Stucki G. Identification of the most common patient problems in patients with chronic conditions using the ICF checklist. J Rehabil Med. 2004;44(Suppl):22–29. doi: 10.1080/16501960410015362.
    1. Stucki G, Cieza A, Geyh S, Battistella L, Lloyd J, Symmons D, Kostanjsek N, Schouten J. ICF Core Sets for rheumatoid arthritis. J Rehabil Med. 2004;44(Suppl):87–93. doi: 10.1080/16501960410015470.
    1. Carr AJ, Hewlett S, Hughes R, Mitchell H, Ryan S, Carr M, Kirwan J. Rheumatology outcomes: the patient's perspective. J Rheumatol. 2003;30:880–883.
    1. Kirwan J, Heiberg T, Hewlett S, Hughes R, Kvien T, Ahlmen M, Boers M, Minnock P, Saag K, Shea B, et al. Outcomes from the Patient Perspective Workshop at OMERACT 6. J Rheumatol. 2003;30:868–872.
    1. Mays N, Pope C. Qualitative research in health care: Assessing quality in qualitative research. BMJ. 2000;320:50–52. doi: 10.1136/bmj.320.7226.50.
    1. Giacomini MK, Cook DJ. Users' guides to the medical literature: XXIII. Qualitative research in health care, A. Are the results of the study valid. JAMA. 2000;284:357–362. doi: 10.1001/jama.284.3.357.
    1. Murphy E, Dingwall R, Greatbatch D, Parker S, Watson P. Qualitative Research Methods in Health Technology Assessment: a Review of the Literature. 16. Vol. 2. Southampton: Health Technology Assessment; 1998.
    1. Sim J. Collecting and analysing qualitative data: issues raised by the focus group. J Adv Nurs. 1998;28:345–352. doi: 10.1046/j.1365-2648.1998.00692.x.
    1. Morgan DL. Focus Groups as Qualitative Research. 2. Thousand Oaks: Sage; Qualitative Research Methods; 1997.
    1. Vaughn S, Schumm JS, Sinagub J. Focus Group Interviews in Education and Psychology. Thousand Oaks: Sage; 1996.
    1. Krueger RA, Casey MA. Focus Groups: a Practical Guide for Applied Research. Thousand Oaks: Sage; 2000.
    1. Morse JM. Critical Issues in Qualitative Research Methods. Thousand Oaks: Sage; 1994.
    1. Morgan DL, Krueger RA. When to use focus groups and why. In: Morgan DL, editor. Successful Focus Groups: Advancing the State of the Art. Newbury Park: Sage; 1993. pp. 3–19.
    1. Kitzinger J. Qualitative research: Introducing focus groups. BMJ. 1995;311:299–302.
    1. Powell RA, Single HM, Lloyd KR. Focus groups in mental health research: enhancing the validity of user and provider questionnaires. Int J Soc Psychiatry. 1996;42:193–206.
    1. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31:315–324.
    1. Patton MQ. Qualitative Evaluation and Research Methods. Newbury Park: Sage; 1990.
    1. Kvale S. Interviews - An Introduction to Qualitative Research Interviewing. California: Sage; 1996.
    1. Karlsson G. Psychological Qualitative Research from a Phenomenological Perspective. Stockholm: Almquist & Wiskell International; 1995.
    1. Cohen J. A coefficient of agreement for nominal scales. Educ Psychol Meas. 1960;20:37–46.
    1. A SAS Macro for Calculating Bootstrapped Confidence Intervals About a kappa Coefficient
    1. Ahlmén M, Nordenskiöld U, Archenholtz B, Thyberg I, Rönnqvist T, Lindén L, Andersson A-K, Mannerkorpi K. Rheumatology outcomes: the patient's perspective. A multicentre focus group interview study of Swedish rheumatoid arthritis patients. Rheumatology. 2005;44:105–110. doi: 10.1093/rheumatology/keh412.
    1. Lambert BL, Butin DN, Moran D, Zhao SZ, Carr BC, Chen C, Kizis FJ. Arthritis care: Comparison of physicians' and patients' views. Semin Arthritis Rheum. 2000;30:100–110. doi: 10.1053/sarh.2000.9203.
    1. Quest E, Aanerud GJ, Kaarud S, Collins S, Leong A, Smedeby B, Denny-Waters A, Mellors R, Taylor D, de Witt M, (Patient Perspective Group) Patients' perspective. J Rheumatol. 2003;30:884–885.
    1. Wirnsberger RM, De Vries J, Jansen TLThA, Van Heck GL, Wouters EFM, Drent M. Impairment of quality of life: rheumatoid arthritis versus sarcoidosis. Neth J Med. 1999;54:86–95. doi: 10.1016/S0300-2977(98)00148-X.
    1. Borchers AT, Keen CL, Cheema GS, Gershwin ME. The use of methotrexate in rheumatoid arthritis. Semin Arthritis Rheum. 2004;34:465–483. doi: 10.1016/j.semarthrit.2003.12.003.
    1. Risley S, Thomas MA, Bray V. Rheumatoid arthritis, new standards of care: nursing implications of infliximab. J Orthop Res. 2004;8:41–49.
    1. Stamm TA, Cieza A, Coenen M, Machold KP, Nell VPK, Smolen JS, Stucki G. Validating the International Classification of Functioning, Disability and Health Comprehensive Core Set for rheumatoid arthritis from the patient perspective: a qualitative study. Arthritis Rheum. 2005;53:431–439. doi: 10.1002/art.21159.
    1. Goodacre LJ, Goodacre JA. Factors influencing the beliefs of patients with rheumatoid arthritis regarding disease-modifying medication. Rheumatology. 2004;43:583–586. doi: 10.1093/rheumatology/keh116.
    1. Deman AM, Brooks PM. Antirheumatic therapy. In: Maddison PJ, Isenberg DA, Woo P, Glass DN, editor. Oxford Textbook of Rheumatology. Oxford: Oxford University Press; 1993. pp. 329–349.
    1. Schattenkirchner M. The use of leflunomide in the treatment of rheumatoid arthritis: an experimental and clinical review. Immunopharmacology. 2000;47:291–298. doi: 10.1016/S0162-3109(00)00194-6.
    1. Brooks PM. Drug modification of inflammation - non-steroidal anti-inflammatory drugs. In: Maddison PJ, Isenberg DA, Woo P, Glass DN, editor. Oxford Textbook of Rheumatology. Oxford: Oxford University Press; 1993. pp. 323–328.
    1. Richy F, Bruyere O, Ethgen O, Rabenda V, Bouvenot G, Audran M, Herrero-Beaumont G, Moore A, Eliakim R, Haim M, Reginster JY. Time dependent risk of gastrointestinal complications induced by non-steroidal anti-inflammatory drug use: a consensus statement using a meta-analytic approach. Ann Rheum Dis. 2004;63:759–766. doi: 10.1136/ard.2003.015925.
    1. Bijlsma JWJ, Boers M, Saag KG, Furst DE. Glucocorticoids in the treatment of early and late RA. Ann Rheum Dis. 2003;62:1033–1037. doi: 10.1136/ard.62.11.1033.
    1. Carnahan MC, Goldstein DA. Ocular complications of topical, peri-ocular, and systemic corticosteroids. Curr Opin Ophthalmol. 2000;11:478–483.
    1. Saag KG. Low-dose corticosteroid therapy in rheumatoid arthritis: balancing the evidence. Am J Med. 1997;103:31S–39S. doi: 10.1016/S0002-9343(97)90006-1.
    1. Saag KG, Koehnke R, Caldwell JR, Brasington R, Burmeister LF, Zimmerman B, Kohler JA, Furst DE. Low dose long-term corticosteroid therapy in rheumatoid arthritis: An analysis of serious adverse events. Am J Med. 1994;96:115–123. doi: 10.1016/0002-9343(94)90131-7.
    1. Axelrod L. Glucocorticoids. In: Kelly WN, Harris ED, Ruddy S, Sledge GB, editor. Textbook of Rheumatology. Philadelphia: WB Saunders; 1993. pp. 779–796.
    1. Berry D, Bradlow A, Bersellini E. Perceptions of the risks and benefits of medicines in patients with rheumatoid arthritis and other painful musculoskeletal conditions. Rheumatology. 2004;43:901–905. doi: 10.1093/rheumatology/keh196.
    1. Marshall NJ, Wilson G, Lapworth K, Kay LJ. Patients' perceptions of treatment with anti-TNF therapy for rheumatoid arthritis: a qualitative study. Rheumatology. 2004;43:1034–1038. doi: 10.1093/rheumatology/keh237.
    1. Westhoff G, Listing J, Zink A. Loss of physical independence in rheumatoid arthritis: Interview data from a representative sample of patients in rheumatologic care. Arthritis Care Res. 2000;13:11–22. doi: 10.1002/1529-0131(200002)13:1<11::AID-ART4>;2-5.
    1. Albers JM, Kuper HH, van Riel PL, Prevoo ML, 't Hof MA, van Gestel AM, Severens JL. Socio-economic consequences of rheumatoid arthritis in the first years of the disease. Rheumatology. 1999;38:423–430. doi: 10.1093/rheumatology/38.5.423.
    1. Walker JG, Littlejohn GO, McMurray NE, Cutolo M. Stress system response and rheumatoid arthritis: a multilevel approach. Rheumatology. 1999;38:1050–1057. doi: 10.1093/rheumatology/38.11.1050.
    1. Evers AWM, Kraaimaat FW, Geenen R, Jacobs JWG, Bijlsma JWJ. Pain coping and social support as predictors of long-term functional disability and pain in early rheumatoid arthritis. Behav Res Ther. 2003;41:1295–1310. doi: 10.1016/S0005-7967(03)00036-6.
    1. Sokka T, Kautiainen H, Mottonen T, Hannonen P. Work disability in rheumatoid arthritis 10 years after the diagnosis. J Rheumatol. 1999;26:1681–1685.
    1. Young A, Dixey J, Cox N, Davies P, Devlin J, Emery P, Gallivan S, Gough A, James D, Prouse P, et al. How does functional disability in early rheumatoid arthritis (RA) affect patients and their lives? Results of 5 years of follow-up in 732 patients from the Early RA Study (ERAS) Rheumatology. 2000;39:603–611. doi: 10.1093/rheumatology/39.6.603.
    1. Doeglas D, Suurmeijer T, Krol B, Sanderman R, van Leeuwen M, van Rijswijk M. Work disability in early rheumatoid arthritis. Ann Rheum Dis. 1995;54:455–460.
    1. Huelsemann JL, Mittendorf T, Merkesdal S, Zeh S, Handelmann S, von der Schulenburg J-M, Zeidler H, Ruof J. Direct costs related to rheumatoid arthritis: The patient perspective. Ann Rheum Dis. 2005;64:1456–1461. doi: 10.1136/ard.2004.031880.
    1. Lapsley HM, March LM, Tribe KL, Cross MJ, Courtenay BG, Brooks PM. Arthritis Cost and Outcome Project Group. Living with rheumatoid arthritis: expenditures, health status, and social impact on patients. Ann Rheum Dis. 2002;61:818–821. doi: 10.1136/ard.61.9.818.
    1. Curtis S, Gesler W, Smith G, Washburn S. Approaches to sampling and case selection in qualitative research: examples in the geography of health. Soc Sci Med. 2000;50:1001–1014. doi: 10.1016/S0277-9536(99)00350-0.
    1. Knodel J. Successful Focus Groups: Advancing the State of the Art. Morgan DL. Newbury Park: Sage; 1993. The design and analysis of focus group studies; pp. 35–50.
    1. Krueger RA. The future of focus groups. Qual Health Res. 1995;5:524–530.
    1. Carey AM. The group effect in focus groups: planning, implementing, and interpreting focus group research. In: Morse JM, editor. Critical Issues in Qualitative Research Methods. Thousand Oaks: Sage; 1994. pp. 225–241.
    1. Zink A, Listing J, Klindworth C, Zeidler H. The national database of the German Collaborative Arthritis Centres: I. Structures, aims, and patients. Ann Rheum Dis. 2001;60:199–206. doi: 10.1136/ard.60.3.199.
    1. Denzin NK. The Research Act: a Theoretical Introduction to Sociological Methods. New York: McGraw-Hill; 1978.
    1. Barbour R. Checklists for improving rigour in qualitative research: a case of the tail wagging the dog? BMJ. 2001;322:1115–1117. doi: 10.1136/bmj.322.7294.1115.
    1. Pope C, Ziebland S, Mays N. Qualitative research in health care: Analysing qualitative data. Br Med J. 2000;320:114–116.
    1. Landis JR, Koch GG. The measurement of observer agreement for categorial data. Biometrics. 1977;33:159–174.

Source: PubMed

Sponsors en medewerkers

Medische omstandigheden

Geneesmiddelinterventies

3
Abonneren